5 studies found for: Open Studies | Hemostatic Disorders | UCSD OR UC San Diego OR VA San Diego
Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib
Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)
ATHN 2: Factor Switching Study
Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Refractory Multiple Myeloma
† Study has passed its completion date and status has not been verified in more than two years.